|
|
Volumn 16, Issue 2, 2001, Pages 147-153
|
|
Evaluation of a new point of care heparin test for cardiopulmonary bypass: The TAS heparin management test
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
AMINOCAPROIC ACID;
ANTICOAGULANT AGENT;
ARGATROBAN;
BLOOD CLOTTING FACTOR 10A;
CLOPIDOGREL;
DANAPAROID;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
HEPARINOID;
HIRUDIN;
LOW MOLECULAR WEIGHT HEPARIN;
PROTAMINE SULFATE;
THROMBIN INHIBITOR;
ADULT;
AGED;
ANALYSIS;
ANTICOAGULATION;
ARTICLE;
BLOOD CLOTTING TIME;
CARDIOPULMONARY BYPASS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEVICE;
DOSE RESPONSE;
DRUG SENSITIVITY;
EVALUATION;
FEMALE;
FIBRINOLYSIS;
HEART SURGERY;
HUMAN;
IN VITRO STUDY;
MALE;
MONITORING;
PATIENT CARE;
PATIENT SELECTION;
PRIORITY JOURNAL;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
SAMPLE;
TECHNIQUE;
THROMBOSIS;
ANTICOAGULANTS;
ANTITHROMBIN III;
BLOOD COAGULATION TESTS;
CARDIAC SURGICAL PROCEDURES;
CARDIOPULMONARY BYPASS;
DRUG MONITORING;
HEPARIN;
HUMANS;
POINT-OF-CARE SYSTEMS;
REFERENCE STANDARDS;
WHOLE BLOOD COAGULATION TIME;
|
|
EID: 0035045735
PISSN: 02676591
EISSN: None
Source Type: Journal
DOI: 10.1177/026765910101600209 Document Type: Article |
|
Times cited : (15)
|
|
References (16)
|
